The fragile structure of p53 gene reveals why this crucial cancer defense is so easily compromised, shedding light on the genetic Achilles' heel of many tumors. In a recent perspective published in ...

Ask yourself how the genetic test results may affect your life. If the results come back positive, will you take steps to ...

A study released by the National Cancer Center Japan has revealed higher rates of mutations in a tumor-suppressing gene, TP53, in Japanese cancer patients compared to those in the United States.

The test, done at Poole Hospital, identified two key genes driving her cancer, ALK fusion and TP53, and doctors prescribed brigatinib, a drug that targets the ALK gene. “Having the ctDNA test results ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

Prince Harry 's ex-girlfriend Cressida Bonas is remembering her late sister Pandora with love.

A 31-year-old woman with stage IV breast cancer learns a test ordered more than a year before her diagnosis detected a TP53 ...

Blood cancer cases are rising alarmingly among young Indians, with leukemia incidences increasing and bone marrow transplants ...

AMSBIO’s CancerSeq™ FFPE tissues provide pre-screened tumour samples validated for single nucleotide polymorphisms (SNPs), ...

Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) announced today that it has regained compliance with Nasdaq for continued listing and that its stock will continue to trade on The ...

Saturation mutagenesis revealed that over half of TP53 missense variants lead to a loss of function, similar to indel variants. Missense variants not found in cancer often retain some residual ...